tamoxifen comprimate 20 mg
naprod life sciences pvt. ltd. - tamoxifenum - comprimate - 20 mg
verzenios
eli lilly nederland b.v. - abemaciclib - sânii neoplasme - agenți antineoplazici - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
vastaloma 250 mg
laboratorios farmalan s.a. - spania - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant cipla 250 mg
laboratorios farmalan, s.a. - spania - fulvestrantum - sol inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
falvax 250 mg
betapharm arzneimittel gmbh - germania - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant sandoz 250 mg
lek pharmaceuticals d.d. - slovenia - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant teva 250 mg
pliva hrvatska d.o.o. (pliva croatia ltd.) - croatia - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant rompharm 250 mg
rompharm company s.r.l. - romania - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant ever pharma 250 mg
ever pharma jena gmbh - germania - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant rompharm 250 mg/5 ml soluţie injectabilă în seringă preumplută
rompharm company srl - fulvestrantum - soluţie injectabilă în seringă preumplută - 250 mg/5 ml